NEW YORK (GenomeWeb News) – Genedata and Bayer Schering Pharma have entered into a multi-year collaboration to develop and use Genedata's Biologics Data Platform at Bayer Schering locations, the companies said today.

Under the agreement, BDP will support biologics data management and analysis at Bayer Schering R&D sites in Europe and the US, which are developing protein-based therapeutics for diseases such as cancer, hemophilia, and multiple sclerosis.

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.

Sponsored by

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.